Advanced Search

 

Study ID Status Title Patient Level Data
114013 Completed Systematic review of the clinical and cost effectiveness of treatments for idiopathic (immune) thrombocytopenic purpura (ITP): direct meta analysis
114014 Completed Indirect Comparison of efficacy of treatments for idiopathic immune thrombocytopenic purpura - review of platelet responses and bleeding events
114015 Completed Meta-analysis of efficacy of Topotecan and other treatments for recurrent carcinoma of the cervix
114016 Completed Indirect Comparison of the efficacy between topotecan and other treatments for recurrent carcinoma of the cervix
114021 Completed A Study of Biomarker Profiles in Asia Pacific erbB2+/HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-erbB2/HER2 Therapy
114025 Completed A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel-Group Study to Compare the Efficacy, Tolerability, and Safety of 3 Doses of Gabapentin Enacarbil (GSK1838262) With Placebo in the Treatment of Subjects With Moderate-to-Severe Primary Restless Legs Syndrome (RLS)
114035 Completed Relative bioavailability study between the formulations: Paroxetine 25 mg tablets with controlled release manufactured by GSK Mississauga and Paroxetine 25 mg tablets with controlled release manufactured by SmithKline Beecham (Cidra), fed administration in healthy volunteers of both genders
114040 Completed Assessment of relative bioavailability of Avandamet 4 mg + 1000 mg (GSK) in the form of film coated tablets versus Avandamet 2 mg + 500 mg (GSK) in the form of film coated tablets, in healthy volunteers after feeding standardized, using Liquid Chromatography.
114041 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of [14C]-GSK2239633 in Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
114043 Active, Not Recruiting Systematic Review and Meta-Analysis of the Impact of Alternative Treatments on Mortality Outcomes in Chronic Obstructive Pulmonary Disease (COPD)
114044 Completed A phase III, randomized, double blind, placebo-controlled clinical study to assess the efficacy and safety of GSK2402968 in subjects with Duchenne muscular dystrophy
114045 Completed Collection of Patients' Background InformationRelenza® Sentinel Site Monitoring Program in Japan
114056 Completed Immunogenicity, safety and reactogenicity of GSK Biologicals’ pneumococcal vaccine 1024850A when administered to children between 8 weeks and 2 years of age
114061 Completed Observational, ecological, database study on epidemiology of hospitalisations with rotavirus gastroenteritis confirmed in children aged 5 years or less, and any impact in the change from lyophilised to liquid formulation of Rotarix™, in Belgium
114068 Completed A Single-centre, Randomised, Double-blind, Placebo-controlled, Escalating Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers Study Listed on ClinicalStudyDataRequest.com
114070 Completed A single-blind, placebo-controlled, two part study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of GSK2018682 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114071 Completed Randomized, two-period, cross-over, bioequivalence study on tamsulosin hydrochloride 0,4 mg prolonged release hard gelatin capsule versus SECOTEX® (tamsulosin hydrochloride) 0,4 mg prolonged release hard gelatin capsule (Boehringer Ingelheim) in healthy male volunteers under fasting conditions.
114073 Completed Randomized, two-period, cross-over, bioequivalence study on tamsulosin hydrochloride 0,4 mg prolonged release hard gelatin capsule versus SECOTEX® (tamsulosin hydrochloride) 0,4 mg prolonged release hard gelatin capsule healthy male volunteers under fed conditions
114078 Completed A multicenter, randomized, double-blind, parallel-group, placebo-controlled study including an open-label phase to evaluate the efficacy and safety of GSK1358820 (botulinum toxin type A) in patients with axillary hyperhidrosis
114083 Completed Long-term follow-up of participants from studies evaluating the HIV vaccine 732462
114089 Completed A Phase I, Randomized, Placebo-Controlled, Crossover Clinical Trial to Assess the Safety of Oral SRT2104 and its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
114092 Completed A multicenter, open-label, dose ranging study to determine the pharmacokinetics and pharmacodynamics of mepolizumab administered intravenously or subcutaneously to adult asthmatic subjects with elevated blood eosinophil levels Study Listed on ClinicalStudyDataRequest.com
114101 Completed Post-marketing safety study to assess the risk of spontaneous abortions in women exposed to Cervarix in the United Kingdom
114102 Completed Special Drug Use Investigation for PAXIL (paroxetine) Social Anxiety Disorder (Long-term)
114107 Completed An open label, randomised healthy volunteer study to assess the single dose safety and pharmacokinetics of three modified release dosage forms of firategrast

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.